Tag: Tx

Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis

WEDNESDAY, Oct. 10, 2018 — Halobetasol propionate 0.01 percent lotion (BRYHALI Lotion) appears safe and effective for the treatment of moderate-to-severe plaque psoriasis, according to the results of two phase 3 trials published in the October issue of the Journal of Drugs in Dermatology. Lawrence J. Green, M.D., from George Washington University in Washington, D.C.,

WHO issues recommendations for Tx intensification in T2DM

(HealthDay)—Recommendations have been developed by the World Health Organization for treatment intensification in type 2 diabetes. The recommendations were published online Sept. 4 in the Annals of Internal Medicine. Gojka Roglic, M.D., and Susan L. Norris, M.D., M.P.H., from the World Health Organization in Switzerland, developed recommendations to provide guidance on medicine selection for treatment

Pharmacologic Tx should be used sparingly for reflux in preemies

(HealthDay)—Conservative measures to control reflux have limited effect on signs of gastroesophageal reflux (GER) in preterm infants, and pharmacologic treatments should be used sparingly, according to a clinical report published online June 18 in Pediatrics. Eric C. Eichenwald, M.D., from the Children’s Hospital of Philadelphia, and colleagues from the American Academy of Pediatrics’ Committee on